Ritechem Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 00639801 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 July 2019

for

Ritechem Pharmacy Limited

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

S Hedayati

REGISTERED OFFICE:

277-279 Chiswick High Road

Chiswick

London

W4 4PU

REGISTERED NUMBER:

00639801 (England and Wales)

ACCOUNTANTS:

Flintham Mackenzie

Chartered Accountants

277-279 Chiswick High Road

Londin

W4 4PU

FIXED ASSETS

Intangible assets

4

1

1

Tangible assets

5

42,989

52,684

Investments

6

177,487

116,437

220,477

169,122

CURRENT ASSETS

Stocks

127,350

141,350

Debtors

174,293

128,812

Cash at bank

13,034

-

314,677

270,162

CREDITORS

Amounts falling due within one year

207,617

123,469

NET CURRENT ASSETS

107,060

146,693

TOTAL ASSETS LESS CURRENT LIABILITIES

327,537

315,815

PROVISIONS FOR LIABILITIES

7

5,948

6,282

NET ASSETS

321,589

309,533

CAPITAL AND RESERVES

Called up share capital

25,371

25,371

Revaluation reserve

8

21,204

21,204

Capital redemption reserve

6,481

6,481

Retained earnings

268,533

256,477

SHAREHOLDERS' FUNDS

321,589

309,533

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 July 2019 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 June 2020 and were signed by:

S Hedayati - Director

1.	STATUTORY INFORMATION

Ritechem Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,

value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost

less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

15% on reducing balance

Computer equipment

-

33% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow

moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to

the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or

substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from

those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that

have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the

timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they

will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension

scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2018 - 4 ) .

4.	INTANGIBLE FIXED ASSETS

Totals

£

COST

At 1 August 2018

and 31 July 2019

121,345

AMORTISATION

At 1 August 2018

and 31 July 2019

121,344

NET BOOK VALUE

At 31 July 2019

1

At 31 July 2018

1

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 August 2018

and 31 July 2019

337,345

DEPRECIATION

At 1 August 2018

284,661

Charge for year

9,695

At 31 July 2019

294,356

NET BOOK VALUE

At 31 July 2019

42,989

At 31 July 2018

52,684

6.	FIXED ASSET INVESTMENTS

Information on loans is as follows:

Totals

£

At 1 August 2018

116,437

Additions

61,050

At 31 July 2019

177,487

7.	PROVISIONS FOR LIABILITIES

2019

2018

£

£

Deferred tax

5,948

6,282

Other

Deferred

provisi-

tax

ons

£

£

Balance at 1 August 2018

6,282

9,203

Provided during year

(334

)

-

Balance at 31 July 2019

5,948

9,203

8.

RESERVES

Revaluat-

ion

reserve

£

At 1 August 2018

and 31 July 2019

21,204